Type 2 & other diabetes

Relationship of neutrophil-to-lymphocyte ratio, in addition to C-reactive protein, with cardiovascular events in patients with type 2 diabetes

Diabetes Res Clin PractPublished Prospective cohort study

Authors' conclusion

In patients with T2D, NLR is related to higher risk of CVD and all-cause mortality, independently from CRP. NLR is related to CVD even when CRP is low, indicating that NLR is a marker of CVD-risk in addition to CRP. Both NLR and CRP are independently related to all-cause mortality in T2D patients.

Study context

Population
Patients with T2D from the UCC-SMART cohort
Participants
1,239 patients10,833 person-years
Exposure
Neutrophil-to-lymphocyte ratio (NLR) and C-reactive protein (CRP) with vascular events and all-cause mortality
Outcome
Vascular events (cerebrovascular events, MI and vascular death) and all-cause mortality
Methodological detailsmultivariable-adjusted Cox regression
  • Multivariable-adjusted Cox regression

Main finding

As reported in the abstract

NLR per SD, adjusted for CRP

Vascular events: HR per SD in NLR

1.27

95% CI 1.11–1.46

All-cause mortality: HR per SD in NLR

1.15

95% CI 1.02–1.30

Events during follow-up: vascular events

232

Events during follow-up: deaths

302

Observational data: associations, not effects.

Further findings

CRP per SD, adjusted for NLR

Vascular events: HR per SD in CRP (95% CI 0.90-1.19); not associated
1.03
All-cause mortality: HR per SD in CRP
1.18 (95% CI 1.04-1.33)
  • Adjusted for NLR

NLR and vascular events in patients with CRP < 2 mg/L

Vascular events: HR per unit NLR
1.45 (95% CI 1.19-1.77)

Original publication

Relationship of neutrophil-to-lymphocyte ratio, in addition to C-reactive protein, with cardiovascular events in patients with type 2 diabetes. Diabetes Res Clin Pract. Published 5 June 2024. doi:10.1016/j.diabres.2024.111727

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.